GERON CORP — Investor Relations & Filings
Filings indexed
1,018
across all filing types
Latest filing
2026-05-06
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
GERN
Geron Corp is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for hematologic malignancies. Its lead product, imetelstat, is a first-in-class telomerase inhibitor approved for the treatment of certain blood cancers. The company's scientific approach targets telomerase to alter the course of hematologic myeloid malignancies, with the goal of extending and enhancing the lives of patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - GERON CORP (0000886744) (Filer) | 2026-05-06 | English | |
| ARS - GERON CORP (0000886744) (Filer) | 2026-04-07 | English | |
| DEF 14A - GERON CORP (0000886744) (Filer) | 2026-04-07 | English | |
| SCHEDULE 13G/A - GERON CORP (0000886744) (Subject) | 2026-03-26 | English | |
| 4 - GERON CORP (0000886744) (Issuer) | 2026-03-26 | English | |
| 3 - GERON CORP (0000886744) (Issuer) | 2026-03-26 | English |
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Centessa Pharmaceuticals plc
Clinical-stage pharmaceutical company developing medicines …
|
CNTA | GB | Manufacturing |
|
Century Therapeutics, Inc.
Develops iPSC-derived allogeneic cell therapies for cancer …
|
IPSC | US | Manufacturing |
|
Cereno Scientific AB
Clinical-stage biotech developing drugs for rare cardiovasc…
|
CRNO | SE | Manufacturing |
|
CERO THERAPEUTICS HOLDINGS, INC.
Immunotherapy company developing engineered T cell therapeu…
|
CERO | US | Manufacturing |
|
CERUS CORP
Develops pathogen inactivation technology to reduce transfu…
|
CERS | US | Manufacturing |
|
Cessatech A/S
A biotech company developing medicines for children's acute…
|
CESSA | DK | Manufacturing |
|
CF PharmTech
Develops and manufactures inhalation drugs and delivery sys…
|
2652 | CN | Manufacturing |
|
CF PharmTech, Inc.
Specialty pharmaceutical company developing complex inhalat…
|
2652 | HK | Manufacturing |
|
CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomic…
|
083790 | KR | Manufacturing |
|
CG Oncology, Inc.
Develops bladder-sparing oncolytic immunotherapies for urol…
|
CGON | US | Manufacturing |
GERON CORP via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32370/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32370 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32370 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32370 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32370}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GERON CORP (id: 32370)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.